Human Rabies Vaccine Market Revenue 2024 to 2034
Human Rabies Vaccine Market Revenue 2024 to 2034
The human rabies vaccine market, worth USD 1.41 billion in 2024, is forecasted to reach USD 2.27 billion by 2034 at a 4.9% CAGR, driven by global vaccination initiatives and rising exposure risks in endemic regions.
Report ID: 10497
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 1.41 Bn
Forecast Year,
USD 2.27 Bn
CAGR, 2025 -
4.90%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Human Rabies Vaccine Market Size Analysis
Human Rabies Vaccine Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vero Cell Vaccine | 0.47 | 0.50 | 0.52 | 0.54 | 0.57 | 0.60 | 0.62 | 0.66 | 0.69 | 0.71 | 0.75 |
| BHK Vaccine | 0.47 | 0.49 | 0.51 | 0.54 | 0.57 | 0.60 | 0.63 | 0.66 | 0.70 | 0.74 | 0.77 |
| Others | 0.47 | 0.49 | 0.52 | 0.54 | 0.57 | 0.59 | 0.62 | 0.65 | 0.67 | 0.72 | 0.76 |
Human Rabies Vaccine Market Size By Prophylaxis 2024 to 2034 (USD )
| Prophylaxis | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre-Exposure (PrEP) | 0.70 | 0.74 | 0.78 | 0.81 | 0.86 | 0.90 | 0.93 | 0.97 | 1.01 | 1.06 | 1.11 |
| Post-Exposure (PEP) | 0.70 | 0.74 | 0.77 | 0.82 | 0.85 | 0.89 | 0.95 | 1.00 | 1.05 | 1.11 | 1.16 |
Human Rabies Vaccine Market Size By End User 2024 to 2034 (USD )
| End User | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 0.47 | 0.49 | 0.51 | 0.54 | 0.57 | 0.60 | 0.63 | 0.65 | 0.69 | 0.72 | 0.75 |
| Clinics | 0.47 | 0.49 | 0.54 | 0.56 | 0.58 | 0.61 | 0.64 | 0.67 | 0.71 | 0.74 | 0.79 |
| Public Health Programs | 0.47 | 0.50 | 0.51 | 0.53 | 0.55 | 0.59 | 0.62 | 0.64 | 0.67 | 0.70 | 0.74 |
Human Rabies Vaccine Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.28 | 0.29 | 0.31 | 0.32 | 0.35 | 0.37 | 0.38 | 0.40 | 0.42 | 0.43 | 0.45 |
| Europe | 0.28 | 0.31 | 0.32 | 0.34 | 0.36 | 0.38 | 0.40 | 0.42 | 0.43 | 0.46 | 0.48 |
| Asia Pacific | 0.28 | 0.29 | 0.31 | 0.34 | 0.35 | 0.36 | 0.37 | 0.40 | 0.42 | 0.43 | 0.44 |
| Latin America | 0.28 | 0.29 | 0.31 | 0.33 | 0.34 | 0.36 | 0.37 | 0.38 | 0.41 | 0.44 | 0.47 |
| Middle East & Africa | 0.28 | 0.30 | 0.31 | 0.31 | 0.32 | 0.33 | 0.36 | 0.37 | 0.38 | 0.41 | 0.42 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
